A regulated path away from peptide black markets

Joe Rogan asks about regulation, and Brigham Buhler argues legal clinical access would reduce dangerous black-market peptides and restore oversight.

Play episode from 01:00:33

Transcript

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!